CORPORATE PRESENTATION J.P. Morgan 39th Annual Healthcare Conference January 2021 SAFE HARBOR STATEMENT This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation are forward-looking statements, including statements regarding: the potential benefits of paltusotine for acromegaly patients and patients with carcinoid syndrome; the potential to initiate a pivotal Phase 3 trial of paltusotine in acromegaly and the expected timin ...